Bisker-Leib Vered

Track

Insider profile

Performance

Overall performance
2.6
Performance over holding periods
2.6
30 days 90 days 120 days
Average return -21% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Bisker-Leib Vered's trades of Compass Therapeutics, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-11-25 2022-11-25
S Sale
67,046 +46.7%
308.66
US$2,894,331 		67,046 +46.7% 308.66 US$2,894,331
2022-11-25 2022-11-23
S Sale
12,231 +6.5%
223.43
US$4,446,907 		12,231 +6.5% 223.43 US$4,446,907
2022-11-25 2022-11-22
S Sale
2,613 -25.5%
486.95
US$3,137,668 		2,613 -25.5% 486.95 US$3,137,668
2022-11-22 2022-11-21
S Sale
16,035 -1.5%
4.34
US$69,592 		16,035 -1.5% 4.34 US$69,592
2022-11-22 2022-11-18
S Sale
6,226 -0.6%
4.40
US$27,394 		6,226 -0.6% 4.40 US$27,394